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A B S T R A C T
BACKGROUND An invasive approach is currently considered superior to medical 
management for the treatment of patients with non-ST-elevation acute coronary syn-
dromes (ACS) (NSTE-ACS). However, the optimal timing of coronary angiography 
and subsequent intervention, if indicated, i.e. immediately after admission or after 
pre-treatment with optimal medical therapy including potent antiplatelet agents, has 
not been settled. Thrombotic material in patients with unstable angina may increase 
the risk of immediate coronary intervention and there is concern that adverse events 
such as myocardial infarction may be increased with routine early intervention. Thus, 
delayed catheterization to allow plaque passivation by pre-treatment with optimal an-
tithrombotic medication has been proposed, particularly since the effectiveness of 
invasive strategies has been enhanced by the widespread use of glycoprotein IIb/IIIa 
inhibitors.
METHODS We have conducted a meta-analysis of randomized trials addressing the 
optimal timing (early versus delayed) of coronary angiography in NSTE-ACS. Four 
trials with 4013 patients were eligible (ABOARD, ELISA, ISAR-COOL, TIMACS), 
and data for longer follow-up periods than those published were contributed to the 
meta-analysis by the ELISA and ISAR-COOL investigators.
RESULTS The median time from admission or randomization to coronary angiogra-
phy ranged from 1.16 to 14 hours in the early, and 20.8 to 86 hours in the delayed strat-
egy group. No statistically significant difference of risk of death (random effects risk 
ratio 0.85, 95% CI 0.64 to 1.11) or myocardial infarction (risk ratio 0.94, 95% CI 0.61 
to 1.45) was detected between the two strategies. The risk for recurrent ischemia was 
significantly reduced for patients assigned to the early strategy (risk ratio 0.59, 95% CI 
0.38 to 0.92, p=0.02). Furthermore, a trend towards decreased major bleeding events 
(risk ratio 0.78, 95% CI 0.57 to 1.07, p=0.13) was observed with the early strategy.
CONCLUSION Early coronary angiography and potential intervention in patients with 
NSTE-ACS reduces the risk of recurrent ischemia and might also reduce major bleed-
ing complications, without affecting mortality and myocardial infarction compared to 
a delayed strategy.
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ABBREVIATIONS
ABOARD= Angioplasty to Blunt the 
Rise of Troponin in Acute Coronary 
Syndromes Randomized for an 
Immediate or Delayed Intervention 
(study)
ACS= acute coronary syndrome(s)
CI= confidence intervals
ELISA= Early or Late Intervention in 
unStable Angina (trial)
ISAR-COOL= Intracoronary Stenting 
With Antithrombotic Regimen Cooling 
Off (study)
NSTE= non-ST elevation
TIMACS= Timing of Intervention 
in Patients With Acute Coronary 
Syndromes (study)
